A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204)
| Title: | A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204) |
|---|---|
| Authors: | Phillips, Tycel J., Avigdor, Abraham, Gurion, Ronit, Patti, Caterina, Corradini, Paolo, Tani, Monica, Mehta, Amitkumar, Lossos, Izidore S., Zinzani, Pier Luigi, Thieblemont, Catherine, Jurczak, Wojciech, Zheng, Fred, Rappold, Erica, Zhao, Wanying, Jiang, Ping, Johnson, Peter |
| Source: | In Blood Advances 27 February 2024 8(4):867-877 |
| Database: | ScienceDirect |
| ISSN: | 24739529 |
|---|---|
| DOI: | 10.1182/bloodadvances.2023010648 |
| Published in: | Blood Advances |
| Language: | English |